Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 2
2021 1
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Escalation vs. Early Intense Therapy in Multiple Sclerosis.
Casanova B, Quintanilla-Bordás C, Gascón F. Casanova B, et al. Among authors: quintanilla bordas c. J Pers Med. 2022 Jan 17;12(1):119. doi: 10.3390/jpm12010119. J Pers Med. 2022. PMID: 35055434 Free PMC article. Review.
Oligoclonal M bands unveil occult inflammation in multiple sclerosis.
Casanova B, Castillo J, Quintanilla-Bordás C, Sanz MT, Fernández-Velasco JI, Alcalá C, Carratalá S, Gasque R, Rubio A, Cubas L, Villar LM, Pérez-Miralles F. Casanova B, et al. Among authors: quintanilla bordas c. Mult Scler Relat Disord. 2022 Dec;68:104118. doi: 10.1016/j.msard.2022.104118. Epub 2022 Aug 15. Mult Scler Relat Disord. 2022. PMID: 36057174
Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience.
Gascón-Giménez F, Alcalá C, Ramió-Torrentà L, Montero P, Matías-Guiu J, Gómez-Estevez I, Oreja-Guevara C, Gil-Perotín S, Blanco Y, Carcelén M, Quintanilla-Bordás C, Costa L, Villar LM, Martínez-Rodriguez JE, Domínguez JA, Calles C, González I, Sotoca J, Oterino A, Lucas-Jimenez C, Pérez-Miralles F, Casanova B. Gascón-Giménez F, et al. Among authors: quintanilla bordas c. Front Neurol. 2023 Mar 7;14:1060696. doi: 10.3389/fneur.2023.1060696. eCollection 2023. Front Neurol. 2023. PMID: 36959824 Free PMC article.
Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis.
Alcalá Vicente C, Lacruz L, Gascón F, Carratalà S, Quintanilla-Bordás C, Sanz MT, Carcelén-Gadea M, Mallada J, Carreres J, Gabaldón Torres L, Dominguez JA, Cañizares E, Gil-Perotin S, Cubas L, Gasqué Rubio R, Castillo-Villalba J, Pérez-Miralles FC, Casanova B. Alcalá Vicente C, et al. Among authors: quintanilla bordas c. Front Neurol. 2022 Oct 28;13:991596. doi: 10.3389/fneur.2022.991596. eCollection 2022. Front Neurol. 2022. PMID: 36388220 Free PMC article.
Eculizumab for a catastrophic relapse in NMOSD: case report.
Gorriz D, Pérez-Miralles FC, Quintanilla-Bordás C, Alcalá C, Frasquet M, Casanova B. Gorriz D, et al. Among authors: quintanilla bordas c. Neurol Sci. 2024 Jan;45(1):249-251. doi: 10.1007/s10072-023-06971-x. Epub 2023 Jul 27. Neurol Sci. 2024. PMID: 37500991
High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
Castillo-Villalba J, Gil-Perotín S, Gasque-Rubio R, Cubas-Nuñez L, Carratalà-Boscà S, Alcalá C, Quintanilla-Bordás C, Pérez-Miralles F, Ferrer C, Cañada Martínez A, Tortosa J, Solís-Tarazona L, Campos L, Leivas A, Laíz Marro B, Casanova B. Castillo-Villalba J, et al. Among authors: quintanilla bordas c. Front Immunol. 2022 Mar 7;13:827738. doi: 10.3389/fimmu.2022.827738. eCollection 2022. Front Immunol. 2022. PMID: 35330910 Free PMC article.
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study.
Alcalá C, Quintanilla-Bordás C, Gascón F, Sempere ÁP, Navarro L, Carcelén-Gadea M, Landete L, Mallada J, Cañizares E, Belenguer A, Carratalá S, Domínguez JA, Pérez-Miralles FC, Gil-Perotín S, Gasqué R, Cubas L, Castillo J, Casanova B. Alcalá C, et al. Among authors: quintanilla bordas c. J Neurol. 2022 Jul;269(7):3676-3681. doi: 10.1007/s00415-022-10989-0. Epub 2022 Feb 2. J Neurol. 2022. PMID: 35107597
Functional and structural changes in the visual pathway in multiple sclerosis.
Carcelén-Gadea M, Quintanilla-Bordás C, Gracia-García A, García-Villanueva C, Jannone-Pedro N, Álvarez-Sánchez L, Vilaplana-Domínguez L, Blanco-Hernández T, Pons-Amate JM, Cervelló-Donderis A. Carcelén-Gadea M, et al. Among authors: quintanilla bordas c. Brain Behav. 2019 Dec;9(12):e01467. doi: 10.1002/brb3.1467. Epub 2019 Nov 16. Brain Behav. 2019. PMID: 31733096 Free PMC article.
Treatment of Multiple Sclerosis With Teriflunomide. Multicenter Study of Real Clinical Practice in the Valencian Community-Spain.
Landete L, Pérez-Miralles F, García S, Belenguer A, Gascón F, Domínguez JA, Carcelén-Gadea M, Quintanilla-Bordás C, Navarro L, Gabaldón L, Casanova B. Landete L, et al. Among authors: quintanilla bordas c. Front Neurol. 2021 Oct 29;12:727586. doi: 10.3389/fneur.2021.727586. eCollection 2021. Front Neurol. 2021. PMID: 34803877 Free PMC article.
13 results